PODCAST: Kari Nadeau, MD, PhD discusses her work on oral immunotherapy with children

A new study found that cell-free DNA from routine prenatal testing can accurately identify preterm birth risk without added cost or procedures.

From the FDA approvals of dupilumab and maralixibat tablets to a new puzzler case study, get caught up with our weekly review article.

Find out how pediatricians play a crucial role in early autism diagnosis and how to advise families post-diagnosis.

The sBLA for dupilumab (Dupixent) was supported by data from the phase 3 LIBERTY-CUPID clinical program in patients with uncontrolled CSU.